# Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis

> **NCT02799472** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 39 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** GSK3196165
- **DRUG:** Placebo
- **DRUG:** MTX
- **DRUG:** Folic (or folinic) acid

## Key facts

- **NCT ID:** NCT02799472
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-15
- **Primary completion:** 2017-10-30
- **Final completion:** 2017-10-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799472, "Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02799472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*